Below is an overview of the key GLP-1 therapies that have shaped the current market landscape: Mounjaro Shakes Up Indias GLP-1 Market Eli Lillys Mounjaro (Tirzepatide) has officially entered the Indian market as the first GLP-1 and GIP (Glucose-Dependent Insulinotropic Polypeptide) dual agonist, marking a significant breakthrough in the treatment of type 2 diabetes and obesity
Characterizations of this state of metabolic crisis have distinguished low fuel (ischemic) states from conditions in which metabolic substrates are available but not effectively utilized (mitochondrial dysfunction)
Protein: 11 g Source: Recipe and photo courtesy of Whitney English, MS, RDN, CPT References 1
Short, readable alerts about device pairing and session timeouts are small touches that make a big difference during peak hours or when toggling between tabs
For urgent concerns, contact your GP, NHS 111, or emergency services if appropriate